Literature DB >> 2009525

Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus.

G D Stoner1, D T Morrissey, Y H Heur, E M Daniel, A J Galati, S A Wagner.   

Abstract

F-344 rats fed diets containing phenethyl isothiocyanate (PEITC; 3 and 6 mumol/g diet), a naturally occurring constituent of cruciferous vegetables, before and during treatment with the carcinogen N-nitrosobenzylmethylamine (NBMA), developed 99-100% fewer esophageal tumors than NBMA-treated control rats. PEITC exhibited inhibitory effects against both preneoplastic lesions (acanthosis and hyperkeratosis, leukoplakia, leukokeratosis) and neoplastic lesions (papilloma, carcinoma). Tumors were not observed in rats treated with PEITC alone. The effects of PEITC (10, 25, 50, 100 microM) on the metabolism and DNA binding of NBMA in cultured explants of rat esophagus were also investigated. PEITC produced a marked (53-97%) dose-dependent inhibition in the binding of NBMA metabolites to DNA and in the levels of DNA methylation at the N7 (20-89%) and O6 (55-93%) positions of guanine. This isothiocyanate also reduced the metabolism of NBMA by esophageal tissues as indicated by increased amounts of unmetabolized NBMA in the medium of cultures containing PEITC. Collectively, these data indicate that PEITC is a potent inhibitor of NBMA-induced esophageal carcinogenesis in rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009525

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.

Authors:  Kozue Sakao; Sudhakar Desineni; Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Prostate       Date:  2011-12-07       Impact factor: 4.104

2.  Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes.

Authors:  Anna A Powolny; Shivendra V Singh
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

3.  Structural and Kinetic Studies of the Effect of Guanine N7 Alkylation and Metal Cofactors on DNA Replication.

Authors:  Yi Kou; Myong-Chul Koag; Seongmin Lee
Journal:  Biochemistry       Date:  2018-08-13       Impact factor: 3.162

4.  p66Shc is indispensable for phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells.

Authors:  Dong Xiao; Shivendra V Singh
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

5.  Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.

Authors:  Dong Xiao; Shivendra Vikram Singh
Journal:  Pharm Res       Date:  2010-02-25       Impact factor: 4.200

6.  Bim contributes to phenethyl isothiocyanate-induced apoptosis in breast cancer cells.

Authors:  Eun-Ryeong Hahm; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2011-07-07       Impact factor: 4.784

Review 7.  Cancer prevention with freeze-dried berries and berry components.

Authors:  Gary D Stoner; Li-Shu Wang; Nancy Zikri; Tong Chen; Stephen S Hecht; Chuanshu Huang; Christine Sardo; John F Lechner
Journal:  Semin Cancer Biol       Date:  2007-05-10       Impact factor: 15.707

Review 8.  Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention.

Authors:  Besma Abbaoui; Christopher R Lucas; Ken M Riedl; Steven K Clinton; Amir Mortazavi
Journal:  Mol Nutr Food Res       Date:  2018-08-29       Impact factor: 5.914

Review 9.  Chemoprevention of esophageal squamous cell carcinoma.

Authors:  Gary D Stoner; Li-Shu Wang; Tong Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-15       Impact factor: 4.219

10.  Carcinogen-altered genes in rat esophagus positively modulated to normal levels of expression by both black raspberries and phenylethyl isothiocyanate.

Authors:  Gary D Stoner; Alan A Dombkowski; Rashmeet K Reen; Daniela Cukovic; Sridevi Salagrama; Li-Shu Wang; John F Lechner
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.